Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Panbela Therapeutics, Inc. | V.P. of Finance & CFO | Stock Option (right to buy) | 25.5K | Oct 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PBLA | Panbela Therapeutics, Inc. | Oct 1, 2024 | 1 | $0 | 4 | Oct 3, 2024 | V.P. of Finance & CFO |
PBLA | Panbela Therapeutics, Inc. | Mar 27, 2023 | 1 | $0 | 4 | Mar 29, 2023 | V.P. of Finance & CFO |
PBLA | Panbela Therapeutics, Inc. | Jan 30, 2023 | 2 | $0 | 4 | Feb 1, 2023 | V.P. of Finance & CFO |
PBLA | Panbela Therapeutics, Inc. | Sep 13, 2021 | 1 | $0 | 4 | Sep 15, 2021 | V.P. of Finance & CFO |